Skip to content

Text Message Reminder-Recalls For Early Childhood Vaccination

Text 4 Health-Kids: Text Message Reminder-Recalls For Early Childhood Vaccination

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01199666
Enrollment
2586
Registered
2010-09-13
Start date
2011-06-30
Completion date
2013-07-31
Last updated
2014-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination

Keywords

Underimmunization, text message, vaccination, Underimmunization

Brief summary

Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized. In addition, pockets of low immunization coverage and outbreaks of vaccine preventable disease persist. Immunization reminder-recalls have been shown to be successful, but have been limited by the ability to identify and reach large target populations in a real-time, automated fashion. Reminder-recalls via text message may offer an innovative opportunity to improve vaccination coverage. Currently, 91% of Americans own a cell phone. Prior research by our team suggests that text messages reminder recalls may be an effective tool to remind parents about their children's vaccines. In this study, the investigators will demonstrate the effectiveness of tailored text message appointment and immunization reminders linked to a well-established and functional immunization registry to increase coverage rates and timeliness of the sentinel vaccines of MMR and HepA. The investigators will target parents of young children from an underserved population that is primarily Latino, with low socioeconomic status.

Interventions

OTHERText message

text message appointment and immunization reminders

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
9 Months to 50 Years
Healthy volunteers
No

Inclusion criteria

* Parents of child \>9 months to 25 months * Child with at least one visit to one of the participating clinical sites in the previous 12 months * Parental cell phone number recorded in the registration system

Design outcomes

Primary

MeasureTime frame
Receipt of MMR1by 13 and 16 months of age

Secondary

MeasureTime frame
Timeliness of HepA vaccination post-recall4,12, 24 weeks
Attendance at appointmentsafter appointment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026